ACE and diabetes mellitus: After starting patients with diabetes on angiotensin-converting enzyme inhibitor (ACEI) drugs, when the serum creatinine increases by <30% without volume depletion, 141 (60.3%) physicians continue the same medication, which is good practice according to the recommendations.